home / stock / vtvt / vtvt news


VTVT News and Press, vTv Therapeutics Inc. From 05/12/22

Stock Information

Company Name: vTv Therapeutics Inc.
Stock Symbol: VTVT
Market: NASDAQ
Website: vtvtherapeutics.com

Menu

VTVT VTVT Quote VTVT Short VTVT News VTVT Articles VTVT Message Board
Get VTVT Alerts

News, Short Squeeze, Breakout and More Instantly...

VTVT - vTv Therapeutics GAAP EPS of -$0.10, revenue of $2M

vTv Therapeutics press release (NASDAQ:VTVT): Q1 GAAP EPS of -$0.10. Revenue of $2M (+100.0% Y/Y). The Company’s cash position as of March 31, 2022, was $12.1 million compared to $13.4 million as of December 31, 2021. For further details see: vTv Therapeutics GAAP EPS of -$0.10, ...

VTVT - vTv Therapeutics Announces 2022 First Quarter Financial Results and Provides Corporate Update

HIGH POINT, N.C., May 12, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter ended March 31, 2022, and provided an update on the progress of its clinical programs. Recent Achievements and Outlook Corporat...

VTVT - vTv Therapeutics GAAP EPS of -$0.11

vTv Therapeutics press release (NASDAQ:VTVT): Q4 GAAP EPS of -$0.11. Revenue of $9K The Company's cash position as of December 31, 2021, was $13.4M compared to $19.6M as of September 30, 2021. For further details see: vTv Therapeutics GAAP EPS of -$0.11

VTVT - vTv Therapeutics Announces 2021 fourth Quarter and Full Year Financial Results and Provides Corporate Update

vTv Therapeutics Announces 2021 fourth Quarter and Full Year Financial Results and Provides Corporate Update PR Newswire HIGH POINT, N.C. , March 29, 2022 /PRNewswire/ -- vTv Therapeutics Inc. (Nasdaq: VTVT) today reported financial results for the fo...

VTVT - vTv therapeutics announces CEO transition

vTv Therapeutics (NASDAQ:VTVT) has appointed Rich Nelson as Acting CEO. Mr. Nelson joined the vTv Board of Directors in 2020, and currently serves as EVP Corporate & Business Development of Vericast, and EVP Corporate Development for MacAndrews & Forbes. Deepa Prasad, who has been ser...

VTVT - vTv Therapeutics Announces CEO Transition

vTv Therapeutics Announces CEO Transition PR Newswire HIGH POINT, N.C. , March 3, 2022 /PRNewswire/ -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diab...

VTVT - Best Penny Stocks to Watch This Coming Week 

3 Penny Stocks For Your Watchlist This Week Buying penny stocks or blue chips right now is not for the faint of heart. While there are a lot of opportunities to make money with penny stocks right now, investors have to have a complete understanding of the current market. For that re...

VTVT - Best Penny Stocks To Buy? 8 Low Float Stocks To Watch Right Now

We discussed this trend on Thursday thanks to the attention that was sparked by shares of ISPO stock. Low float penny stocks are gaining even more attention in the stock market today thanks to the massive breakout potential that they can hold. In looking at the ISPO example, the small-c...

VTVT - vTv Therapeutics Shares Updated Corporate Presentation

HIGH POINT, N.C., Jan. 13, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company committed to improving the quality of life for people with diabetes, is sharing its updated corporate presentation highlighting its lead program TTP399, a...

VTVT - NVAX, BPMP and FSM among pre market gainers

Can-Fite BioPharma (NYSE:CANF) +71% liver cancer patient treated with can-Fite’s Namodenoson clears all cancer lesions under open label extension of phase II study. Society Pass Incorporated (NASDAQ:SOPA) +35% on being added to the Russell 2000 Index. Verso (NYSE:VRS) +3...

Previous 10 Next 10